NDC 82804-147 – Metformin
Metformin Hydrochloride 500 mg/1 · Tablet, Extended Release · Oral
Product NDC82804-147
Product details
- Brand name
- Metformin
- Generic name
- Metformin ER 500 mg
- Labeler
- Proficient Rx LP
- Dosage form
- Tablet, Extended Release
- Route
- Oral
- Marketing category
- ANDA · ANDA209313
- Marketed since
- July 31, 2018
- Listing expires
- December 31, 2026
- Pharmacologic class
- Biguanide
Active ingredients
- Metformin Hydrochloride 500 mg/1
Package NDC codes (4)
| Package NDC | Description | Since |
|---|---|---|
| 82804-147-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (82804-147-30) | Apr 8, 2025 |
| 82804-147-60 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (82804-147-60) | Sep 20, 2024 |
| 82804-147-78 | 180 TABLET, EXTENDED RELEASE in 1 BOTTLE (82804-147-78) | Oct 1, 2024 |
| 82804-147-90 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (82804-147-90) | Nov 4, 2024 |
Other Metformin products
- 50090-6516 Metformin Hydrochloride 500 mg/1 · Tablet, Extended Release · A-S Medication Solutions
- 50090-7372 Metformin Hydrochloride 750 mg/1 · Tablet, Extended Release · A-S Medication Solutions
- 50090-7373 Metformin Hydrochloride 750 mg/1 · Tablet, Extended Release · A-S Medication Solutions
- 72162-2424 Metformin Hydrochloride 500 mg/1 · Tablet, Extended Release · Bryant Ranch Prepack
- 71335-2524 Metformin Hydrochloride 750 mg/1 · Tablet, Extended Release · Bryant Ranch Prepack
- 71335-2354 Metformin Hydrochloride 500 mg/1 · Tablet, Extended Release · Bryant Ranch Prepack
- 67046-0437 Metformin Hydrochloride 500 mg/1 · Tablet, Extended Release · Coupler LLC
- 67046-1557 Metformin Hydrochloride 500 mg/1 · Tablet, Extended Release · Coupler LLC
- 67046-1584 Metformin Hydrochloride 1000 mg/1 · Tablet, Extended Release · Coupler LLC
- 70010-491 Metformin Hydrochloride 500 mg/1 · Tablet, Extended Release · Granules Pharmaceuticals Inc.
- 70010-492 Metformin Hydrochloride 750 mg/1 · Tablet, Extended Release · Granules Pharmaceuticals Inc.
- 50742-634 Metformin Hydrochloride 1000 mg/1 · Tablet, Extended Release · Ingenus Pharmaceuticals, LLC